---
title: "Blood protein assessment of leading incident diseases and mortality in the UK Biobank"
description: |
  * **Objective**: To identify and validate protein biomarkers for the 10-year incidence of 23 age-related diseases and all-cause mortality using proteomics data from **47,600 UK Biobank participants**.
  * **Key Result**: Multi-protein risk scores (**ProteinScores**), developed using penalized Cox regression, significantly **improved the Area Under the Curve (AUC)** for the 10-year onset prediction of **six major outcomes**, including all-cause mortality, coronary artery disease (CAD), and Type 2 diabetes (T2D), even after adjusting for 24 comprehensive clinical and lifestyle factors.
  * **Implication**: The ProteinScores capture independent biological information related to underlying **aging and systemic disease risk** not found in standard clinical measures, validating the use of multi-protein panels for enhanced personalized risk stratification.
date: last-modified
categories: [aging, biomarkers, machine learning, mortality, proteomics, risk prediction]
---
**PubMed:** [38987645](https://pubmed.ncbi.nlm.nih.gov/38987645/)
**DOI:** [10.1038/s43587-024-00655-7](https://doi.org/10.1038/s43587-024-00655-7)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Key Findings: Protein Scores Predict Incident Disease and Mortality

This large-scale study leveraged proteomics data from the **UK Biobank (n=47,600)** to identify and validate protein biomarkers for the risk of 23 common age-related diseases and all-cause mortality. The core finding is that **multi-protein scores ("ProteinScores")** significantly enhance the prediction of incident diseases and mortality, even when accounting for comprehensive clinical and lifestyle information.

### Discovery of Associations
* The study reported **3,209 associations** between 963 unique plasma protein levels and 21 incident outcomes (including diseases and mortality).
* **Cardiovascular disease (CVD)**, specifically **coronary artery disease (CAD)** and **atrial fibrillation (AF)**, had the largest number of associated proteins, highlighting the strong systemic link between the proteome and heart health.

### Predictive Power of ProteinScores
* **ProteinScores** were developed using penalized Cox regression (elastic net) to combine multiple protein measurements into a single risk score for each outcome.
* These scores were applied to independent test sets and were found to **improve the Area Under the Curve (AUC)** estimates for the 10-year onset of incident outcomes, **beyond** a minimally adjusted model that already included age, sex, and a comprehensive set of 24 lifestyle and clinical factors.
* ProteinScores were validated for **six major outcomes**, including:
    * **All-cause mortality**
    * **Coronary artery disease (CAD)**
    * **Atrial fibrillation (AF)**
    * **Type 2 diabetes (T2D)**
    * **Colorectal cancer (CRC)**
    * **Glaucoma**

## Methods and Design

### Cohort and Data
* **Participants:** Up to 47,600 individuals from the UK Biobank.
* **Proteome:** Measured levels for **1,468 plasma proteins** using the Olink Proximity Extension Assay (PEA) platform.
* **Outcomes:** Incident diagnoses for 23 age-related diseases and all-cause mortality, monitored over a 10-year follow-up period.

### Statistical Modeling
1.  **Individual Protein Associations:** Cox proportional hazards (PH) models were used to test the association between each individual protein and each outcome.
2.  **ProteinScore Development:** **Penalized Cox regression (elastic net)** was employed across 50 randomized iterations of training/testing to select and weight the most predictive proteins for each outcome, resulting in a single, robust **ProteinScore**.
3.  **Benchmarking:** ProteinScore performance was rigorously compared to a **minimally adjusted model** (age, sex, and 24 clinical/lifestyle factors) using the **incremental AUC difference ($\Delta$AUC)**, with 10-year AUC being the primary metric.

## Results: Biological Insights and Clinical Relevance

### Mortality and Aging
The ProteinScore for **all-cause mortality** was consistently one of the strongest performers. The proteins contributing most to the mortality score were related to fundamental biological pathways such as **inflammation** (e.g., C-Reactive Protein, CRP) and **cellular stress/damage**. The study demonstrated that protein levels capture biological information related to underlying aging processes that are independent of standard clinical risk factors.

### Disease Specificity
* **CAD and AF:** ProteinScores for these cardiovascular outcomes showed significant predictive improvement, highlighting the utility of proteomics in risk stratification for heart disease.
* **CRC and Glaucoma:** The successful prediction of these conditions demonstrates that plasma proteomics can capture systemic signals of diseases that are often viewed as localized.

## Conclusions and Recommendations

The study confirms that **plasma protein levels are powerful predictors** of future health outcomes and mortality. The **ProteinScore approach** provides a robust, validated, and clinically actionable method for integrating this proteomic information into risk stratification models. The authors advocate for the routine use of multi-protein panels to improve personalized risk assessment for major age-related diseases and overall longevity.
